FDA Grants Breakthrough Therapy Designation to AlphaMedix for Gastroenteropancreatic …

A total of 5 grade 3 AEs were reported: acute kidney injury, back pain, dysarthria, and dyspnea. No grade 4 AEs occurred, and 1 grade 5 AE was …
Source: back pain